|
|
|
|
Vol. 11, Issue 3, 1061-1076, March 2000
1 Selectively Inhibits
the Cyclic AMP-dependent Proliferation of Primary Thyroid Epithelial
Cells by Preventing the Association of Cyclin D3-cdk4 with Nuclear
p27kip1

*Institute of Interdisciplinary Research, Université Libre de
Bruxelles, Campus Erasme, B-1070 Brussels, Belgium; and
Dog thyroid epithelial cells in primary culture constitute
a physiologically relevant model of positive control of DNA synthesis initiation and G0-S prereplicative phase progression by cAMP as a
second messenger for thyrotropin (thyroid-stimulating hormone [TSH]).
As previously shown in this system, the cAMP-dependent mitogenic
pathway differs from growth factor cascades as it stimulates the
accumulation of p27kip1 but not cyclins D. Nevertheless,
TSH induces the nuclear translocations and assembly of cyclin D3 and
cdk4, which are essential in cAMP-dependent mitogenesis. Here we
demonstrate that transforming growth factor
Division of Cancer Biology, Danish Cancer Society,
DK-2100 Copenhagen, Denmark
1
(TGF
1) selectively inhibits the cAMP-dependent cell
cycle in mid-G1 and various cell cycle regulatory events, but it weakly affects the stimulation of DNA synthesis by epidermal growth factor (EGF), hepatocyte growth factor, serum, and phorbol esters. EGF+serum and TSH did not interfere importantly with TGF
receptor signaling, because they did not affect the TGF
-induced nuclear translocation of
Smad 2 and 3. TGF
inhibited the phosphorylation of Rb, p107, and
p130 induced by TSH, but it weakly affected the phosphorylation state
of Rb-related proteins in EGF+serum-treated cells. TGF
did not
inhibit c-myc expression. In TSH-stimulated
cells, TGF
did not affect the expression of cyclin D3, cdk4, and
p27kip1, nor the induced formation of cyclin D3-cdk4
complexes, but it prevented the TSH-induced relocalization of
p27kip1 from cdk2 to cyclin D3-cdk4. It prevented the
nuclear translocations of cdk4 and cyclin D3 without altering the
assembly of cyclin D3-cdk4 complexes probably formed in the cytoplasm,
where they were prevented from sequestering nuclear p27kip1
away from cdk2. This study dissociates the assembly of cyclin D3-cdk4
complexes from their nuclear localization and association with
p27kip1. It provides a new mechanism of regulation of
proliferation by TGF
, which points out the subcellular location of
cyclin D-cdk4 complexes as a crucial factor integrating
mitogenic and antimitogenic regulations in an epithelial cell in
primary culture.
Corresponding author. E-mail address:
proger{at}ulb.ac.be.
This article has been cited by other articles:
![]() |
A. S. Rocha, S. Paternot, K. Coulonval, J. E. Dumont, P. Soares, and P. P. Roger Cyclic AMP Inhibits the Proliferation of Thyroid Carcinoma Cell Lines through Regulation of CDK4 Phosphorylation Mol. Biol. Cell, November 1, 2008; 19(11): 4814 - 4825. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paternot, J. E. Dumont, and P. P. Roger Differential Utilization of Cyclin D1 and Cyclin D3 in the Distinct Mitogenic Stimulations by Growth Factors and TSH of Human Thyrocytes in Primary Culture Mol. Endocrinol., December 1, 2006; 20(12): 3279 - 3292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Matsuo, S. G. Leoni, A. Colquhoun, and E. T. Kimura Transforming growth factor-{beta}1 and activin A generate antiproliferative signaling in thyroid cancer cells. J. Endocrinol., July 1, 2006; 190(1): 141 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bockstaele, H. Kooken, F. Libert, S. Paternot, J. E. Dumont, Y. de Launoit, P. P. Roger, and K. Coulonval Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK "Inhibitors". Mol. Cell. Biol., July 1, 2006; 26(13): 5070 - 5085. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fortemaison, S. Blancquaert, J. E. Dumont, C. Maenhaut, K. Aktories, P. P. Roger, and S. Dremier Differential Involvement of the Actin Cytoskeleton in Differentiation and Mitogenesis of Thyroid Cells: Inactivation of Rho Proteins Contributes to Cyclic Adenosine Monophosphate-Dependent Gene Expression but Prevents Mitogenesis Endocrinology, December 1, 2005; 146(12): 5485 - 5495. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter Endocr. Rev., June 1, 2005; 26(4): 504 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Edmiston, W. A. Yeudall, T. D. Chung, and D. A. Lebman Inability of Transforming Growth Factor-{beta} to Cause SnoN Degradation Leads to Resistance to Transforming Growth Factor-{beta}-Induced Growth Arrest in Esophageal Cancer Cells Cancer Res., June 1, 2005; 65(11): 4782 - 4788. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cheng, M. A. Thompson, H. J. Walker, C. E. Gray, M. M. Diaz Encarnacion, G. M. Warner, and J. P. Grande Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4 Am J Physiol Renal Physiol, November 1, 2004; 287(5): F940 - F953. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Lewis, A. J. Fikaris, G. V. Prendergast, and J. L. Meinkoth Thyrotropin and Serum Regulate Thyroid Cell Proliferation through Differential Effects on p27 Expression and Localization Mol. Endocrinol., September 1, 2004; 18(9): 2321 - 2332. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Siegel, W. Shu, and J. Massague Mad Upregulation and Id2 Repression Accompany Transforming Growth Factor (TGF)-{beta}-mediated Epithelial Cell Growth Suppression J. Biol. Chem., September 12, 2003; 278(37): 35444 - 35450. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paternot, K. Coulonval, J. E. Dumont, and P. P. Roger Cyclic AMP-dependent Phosphorylation of Cyclin D3-bound CDK4 Determines the Passage through the Cell Cycle Restriction Point in Thyroid Epithelial Cells J. Biol. Chem., July 11, 2003; 278(29): 26533 - 26540. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bollard, C. Rossig, M. J. Calonge, M. H. Huls, H.-J. Wagner, J. Massague, M. K. Brenner, H. E. Heslop, and C. M. Rooney Adapting a transforming growth factor beta -related tumor protection strategy to enhance antitumor immunity Blood, May 1, 2002; 99(9): 3179 - 3187. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models Endocr. Rev., October 1, 2001; 22(5): 631 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wolff, P. A. Harper, J. M. Y. Wong, V. Mostert, Y. Wang, and J. Abel Cell-Specific Regulation of Human Aryl Hydrocarbon Receptor Expression by Transforming Growth Factor-{beta}1 Mol. Pharmacol., April 1, 2001; 59(4): 716 - 724. [Abstract] [Full Text] |
||||
![]() |
A. Van Keymeulen, S. Deleu, J. Bartek, J. E. Dumont, and P. P. Roger Respective Roles of Carbamylcholine and Cyclic Adenosine Monophosphate in Their Synergistic Regulation of Cell Cycle in Thyroid Primary Cultures Endocrinology, March 1, 2001; 142(3): 1251 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Charland, M.-J. Boucher, M. Houde, and N. Rivard Somatostatin Inhibits Akt Phosphorylation and Cell Cycle Entry, But Not p42/p44 Mitogen-Activated Protein (MAP) Kinase Activation in Normal and Tumoral Pancreatic Acinar Cells Endocrinology, January 1, 2001; 142(1): 121 - 128. [Abstract] [Full Text] [PDF] |
||||